Skip to content

Preoperative Gabapentin Administration Improves Postoperative Analgesia in Patients Undergoing Laparoscopic Radical Resection of Colorectal Cancer

Preoperative Gabapentin Administration Improves Postoperative Analgesia in Patients Undergoing Laparoscopic Radical Resection of Colorectal Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022555
Enrollment
Unknown
Registered
2019-04-16
Start date
2019-04-12
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

two groups: gabapentin

Sponsors

General Hospital of Southern Theater Command, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who were recruited for laparoscopic radical resection of colorectal cancer were enrolled in the study. Inclusion criteria were between the ages of 18 and 70 year, as well as the physical condition of (ASA) I or II of the American Society of anesthesiologists.

Exclusion criteria

Exclusion criteria: If patients meet at least one of the following criteria, they are excluded from the scope of the study: body mass index (BMI) > 30, history of mental or mental illness, communication disorder, pregnancy or lactation of female patients, History of systemic malignant tumors, epilepsy, allergies to drugs used in the study, drug or alcohol addiction, history of drug bleeding, digestive tract ulcers, kidney or liver dysfunction, severe cardiovascular disease and severe hypertension, aspirin, Hypersensitivity of sulfonamides; Keywords bronchial asthma; existing coagulation disorder; use of analgesic drugs within 48 hours before operation; participation in another experimental study within 30 days before operation; drug abuse and chronic pain; conversion to open surgery during operation; If other operations are performed at the same time, the patient will be also excluded.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale/Score;Opioid consumption;nausea and vomitting;

Secondary

MeasureTime frame
Recovery quality;

Countries

China

Contacts

Public ContactXi Wenbin

General Hospital of Southern Theater Command, PLA

2974500365@QQ.coM+86 13729848200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026